on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has revealed details of its interest in Mural Oncology plc, complying with Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure is pertinent to parties possessing interests of 1% or greater in relevant securities. The latest data available is as of July 3, 2025.
The Vanguard Group controls 772,819 ordinary shares, representing a 4.48% stake in Mural Oncology. There have been no dealings involving cash or stock-settled derivatives. However, a small sale of 16 ordinary shares at $2.58 per unit was reported. There are no reported indemnities, agreements, options, or derivative arrangements related to this holding.
No additional parties or transactions were disclosed, and a Supplemental Form 8 is not attached to this document.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news